Newsroom
Category
March 3, 2022
The FDA has approved pacritinib for myelofibrosis patients with low platelet counts. Investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, played a lead role in gaining U.S. Food and Drug Administration approval of pacritinib to treat the chronic leukemia known as myelofibrosis. The FDA granted accelerated approval of the […]
March 2, 2022
Dr. Ruben Mesa, Mays Cancer Center, is quoted in this article. Read More
March 1, 2022
Dr. Ruben Mesa, executive director of the Mays Cancer Center, gives video comments about FDA approval of a new drug for a chronic leukemia. Watch Video
February 24, 2022
During a visit to the Mays Cancer Center, Biden spoke to patients and doctors about the disparities of cancer care among Latinos. The Biden administration, along with the first lady, have advocated for jumpstarting cancer screenings that were missed or delayed due to the COVID-19 pandemic and ensure that tools to detect and treat cancer […]
February 24, 2022
During a visit to the Mays Cancer Center, Biden spoke about the disparities of cancer care among Latinos and highlighted the importance of combating language and cultural barriers to make better care possible among the community. Read story
February 24, 2022
The visit comes after the Biden administration announced the restart of the Cancer Moonshot initiative earlier this month. Read story